Dr. Silina is a Swiss National Science Foundation (SNSF) PRIMA group leader at the Institute of Pharmaceutical Sciences (IPW) at the ETH Zurich. In 2022, Dr. Silina started her own laboratory at the IPW, where her ongoing research efforts aim to define the physiological role and mechanisms of development of tertiary lymphoid structure (TLS) in cancer, which could potentially be manipulated as a novel immunotherapeutic approach.
Media
Are you sure you want to reset your password?
If so, you will be redirected to the Authentication Service
